1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Cerebellar Ataxia Global Clinical Trials Review, H1, 2014

Cerebellar Ataxia Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Cerebellar Ataxia Global Clinical Trials Review, H1, 2014" provides data on the Cerebellar Ataxia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cerebellar Ataxia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cerebellar Ataxia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Cerebellar Ataxia Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Cerebellar Ataxia 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Cerebellar Ataxia to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Cerebellar Ataxia to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Drugs 25
Clinical Trial Overview of Top Institutes / Government 26
S. Andrea Hospital Sapienza Rome University 26
Clinical Trial Overview of S. Andrea Hospital Sapienza Rome University 26
Office of Rare Diseases, National Institutes of Health 27
Clinical Trial Overview of Office of Rare Diseases, National Institutes of Health 27
National Institute of Neurological Disorders and Stroke 28
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 28
General Hospital of Chinese Armed Police Forces 29
Clinical Trial Overview of General Hospital of Chinese Armed Police Forces 29
Fundacion Para La Investigacion Biomedica Del Hospital Universitarios La Paz 30
Clinical Trial Overview of Fundacion Para La Investigacion Biomedica Del Hospital Universitarios La Paz 30
Ministry of Health, Labour and Welfare, Japan 31
Clinical Trial Overview of Ministry of Health, Labour and Welfare, Japan 31
Assistance Publique - Hopitaux de Paris 32
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 32
National Yang Ming University 33
Clinical Trial Overview of National Yang Ming University 33
Charite - Universitatsmedizin Berlin 34
Clinical Trial Overview of Charite - Universitatsmedizin Berlin 34
Five Key Clinical Profiles 35
Appendix 49
Abbreviations 49
Definitions 49
Research Methodology 50
Secondary Research 50
About GlobalData 51
Contact Us 51
Disclaimer 51
Source 51

List of Tables
Cerebellar Ataxia Therapeutics, Global, Clinical Trials by Region, 2014* 6
Cerebellar Ataxia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Cerebellar Ataxia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Cerebellar Ataxia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Cerebellar Ataxia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Cerebellar Ataxia Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Cerebellar Ataxia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 12
Proportion of Cerebellar Ataxia to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Cerebellar Ataxia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Cerebellar Ataxia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Cerebellar Ataxia to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Cerebellar Ataxia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Cerebellar Ataxia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Cerebellar Ataxia Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Cerebellar Ataxia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Cerebellar Ataxia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Cerebellar Ataxia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Cerebellar Ataxia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Cerebellar Ataxia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Cerebellar Ataxia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
Cerebellar Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by S. Andrea Hospital Sapienza Rome University, 2014* 26
Cerebellar Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by Office of Rare Diseases, National Institutes of Health, 2014* 27
Cerebellar Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 28
Cerebellar Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by General Hospital of Chinese Armed Police Forces, 2014* 29
Cerebellar Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacion Para La Investigacion Biomedica Del Hospital Universitarios La Paz, 2014* 30
Cerebellar Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Health, Labour and Welfare, Japan, 2014* 31
Cerebellar Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 32
Cerebellar Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Yang Ming University, 2014* 33
Cerebellar Ataxia Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2014* 34

List of Figures
Cerebellar Ataxia Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Cerebellar Ataxia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Cerebellar Ataxia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Cerebellar Ataxia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Cerebellar Ataxia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Cerebellar Ataxia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Cerebellar Ataxia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 12
Proportion of Cerebellar Ataxia to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Cerebellar Ataxia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Cerebellar Ataxia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Cerebellar Ataxia to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Cerebellar Ataxia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Cerebellar Ataxia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Cerebellar Ataxia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Cerebellar Ataxia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Cerebellar Ataxia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Cerebellar Ataxia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Cerebellar Ataxia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Cerebellar Ataxia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Cerebellar Ataxia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
GlobalData Methodology 50

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.